Search hospitals > Wisconsin > Mukwonago

ProHealth D N Greenwald Center

Claim this profile
Mukwonago, Wisconsin 53149
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Recurrence
Conducts research for Non-Small Cell Lung Cancer
154 reported clinical trials
1 medical researcher
Photo of ProHealth D N Greenwald Center in MukwonagoPhoto of ProHealth D N Greenwald Center in MukwonagoPhoto of ProHealth D N Greenwald Center in Mukwonago

Summary

ProHealth D N Greenwald Center is a medical facility located in Mukwonago, Wisconsin. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Recurrence, Non-Small Cell Lung Cancer and other specialties. ProHealth D N Greenwald Center is involved with conducting 154 clinical trials across 281 conditions. There are 1 research doctors associated with this hospital, such as Timothy Wassenaar, MD.

Area of expertise

1Cancer
Global Leader
ProHealth D N Greenwald Center has run 71 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Lung Cancer
Global Leader
ProHealth D N Greenwald Center has run 30 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II

Top PIs

Clinical Trials running at ProHealth D N Greenwald Center

Breast Cancer
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Bladder Cancer
Squamous Cell Carcinoma
Bladder Carcinoma
Renal Cell Carcinoma
Cutaneous Melanoma
Rectal Cancer
Image of trial facility.

Radiation and HER2-Targeted Therapy

for Breast Cancer

This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Image of trial facility.

Omitting Radiation Therapy

for Breast Cancer

This study is evaluating whether a type of radiation therapy may help prevent breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Pembrolizumab

for Triple-Negative Breast Cancer

The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria

Similar Hospitals nearby

Select from list below to view details

Frequently asked questions

What kind of research happens at ProHealth D N Greenwald Center?
ProHealth D N Greenwald Center is a medical facility located in Mukwonago, Wisconsin. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Recurrence, Non-Small Cell Lung Cancer and other specialties. ProHealth D N Greenwald Center is involved with conducting 154 clinical trials across 281 conditions. There are 1 research doctors associated with this hospital, such as Timothy Wassenaar, MD.